Mehrdad Khezri

Mehrdad Khezri

Auto-generated profile, based on publicly available information

Mehrdad Khezri

Department of Epidemiology, School of Global Public Health, New York University , New York, NY

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 June 2020 in International Journal of STD & AIDS
Verified
Journal Article
Closed access
PDF file
MKMehrdad Khezri
Mehrdad Khezri
MSMostafa Shokoohi
Mostafa Shokoohi
AMAli Mirzazadeh
Ali Mirzazadeh
MKMohammad Karamouzian
Mohammad Karamouzian
HSHamid Sharifi
Hamid Sharifi
SBStefan D Baral
Stefan D Baral
Early sex work initiation among female sex workers (FSWs) increases their vulnerabilities to high-risk sexual practices and sexually transmitted infections (STIs). We examined the association of early sex work with condomless sex indicators, HIV, and other STIs, including human papillomavirus, chlamydia, trichomoniasis, syphilis, and gonorrhea, among FSWs in Iran. We recruited 1347 FSWs from 13 cities in 2015, with 1296 participants (94.2%) reporting information about their age of sex work initiation. Early sex work was defined as the initiation of selling sex before 18 years of age. Adjusted odds ratios (aORs) and 95% confidence intervals (CIs) were reported using multivariable logistic regression. Overall, 10.1% of FSWs reported early sex work initiation. FSWs who initiated sex work earlier were more likely to report last-month inconsistent condom use (aOR = 3.31, 95% CI: 1.82, 6.02) and condomless sex with last client (aOR = 1.72, 95% CI: 1.15, 2.56). There was no statistically significant association between early sex work and HIV (aOR = 1.40, 95% CI: 0.43, 4.53) and any other STIs (aOR = 1.01, 95% CI: 0.69, 1.48), except for chlamydia (aOR = 2.09, 95% CI: 1.08, 4.04). These findings suggest that FSWs with early sexual debut would benefit from differentiated interventions including screening for STIs and enhanced counseling for condom use.

11 October 2021 in Sexuality & Culture
Verified
Journal Article
Closed access
PDF file
MSMostafa Shokoohi
Mostafa Shokoohi
MKMehrdad Khezri
Mehrdad Khezri
MKMohammad Karamouzian
Mohammad Karamouzian
AMAli Mirzazadeh
Ali Mirzazadeh

17 September 2020 in The European Journal of Contraception & Reproductive Health Care
Verified
Journal Article
Closed access
MKMehrdad Khezri
Mehrdad Khezri
MSMostafa Shokoohi
Mostafa Shokoohi
MKMohammad Karamouzian
Mohammad Karamouzian
AMAli Mirzazadeh
Ali Mirzazadeh
NGNima Ghalekhani
Nima Ghalekhani
HSHamid Sharifi
Hamid Sharifi
Induced abortion is an occupational hazard for female sex workers (FSWs). This study aimed to examine the prevalence and factors associated with induced abortion among FSWs in Iran. 1337 FSWs aged ...

5 December 2022 in BMC Infectious Diseases
Verified
Journal Article
Open access
PDF file
FTFatemeh Tavakoli
Fatemeh Tavakoli
NPNajmeh Parhizgari
Najmeh Parhizgari
MSMostafa Shokoohi
Mostafa Shokoohi
MKMehrdad Khezri
Mehrdad Khezri
AHAliakbar Haghdoost
Aliakbar Haghdoost
HSHamid Sharifi
Hamid Sharifi
Background: Incarcerated people are at a disproportionate risk of contracting HIV. We estimated the prevalence and correlates of HIV testing among incarcerated people with a history of HIV-related high-risk behaviours in Iran. Methods: Data for this analysis were obtained from three consecutive nationwide bio-behavioural surveillance surveys of a random sample of incarcerated people in 2009 (n = 5953), 2013 (n = 5490), and 2017 (n = 5785). History of testing for HIV in the last 12 months was the primary outcome variable. HIV testing was examined among those with a history of HIV-related high-risk behaviours (i.e., having multiple sex partnerships, injection drug use practices, or a history of having a tattoo). The outcome variable was divided into three categories: Never tested for HIV, ever tested for HIV inside the prison in the last 12 months, and ever tested for HIV outside the prison in the last 12 months. We used multivariable multinomial logistic regression models to examine factors associated with HIV testing. Results: Overall, 8,553 participants with a history of HIV-related high-risk behaviors with valid responses to the HIV testing question were included in the analysis. Although HIV testing inside prison has increased (23% [2009], 21.5% [2013], and 50.3% [2017]: P-value < 0.001), the prevalence of HIV testing outside prison has decreased (7.7% [2009], 7.5% [2013], 4.1% [2017]: P-value < 0.001) over time. Our multivariable multinomial regression model showed older age (Relative-risk ratio [RRR]: 1.24, 95% Confidence Intervals [CI]: 1.05, 1.47), history of the previous incarceration (RRR: 1.46, 95% CI: 1.24, 1.71), currently receiving methadone maintenance therapy inside prison (RRR: 2.09, 95% CI: 1.81, 2.43), having access to condoms inside prison (RRR: 1.42, 95% CI: 1.20, 1.68) and sufficient HIV knowledge (RRR: 1.74, 95% CI: 1.47, 2.05) were significantly associated with an increased probability of having an HIV test in the last 12 months inside prison. Conclusion: HIV testing among high-risk Iranian prisoners has increased from 2009 to 2017. However, HIV testing remains considerably low, and half of the incarcerated people with a history of HIV-related high-risk behaviours had never tested for HIV inside prison. Evidence-based programs are needed to optimize HIV testing inside and outside prisons and identify those at greater risk of HIV.

26 April 2025 in International Journal of Drug Policy
Verified
Journal Article
Closed access
MKMehrdad Khezri
Mehrdad Khezri
SKSarah Kimball
Sarah Kimball
CMCourtney McKnight
Courtney McKnight
SRSaba Rouhani
Saba Rouhani
ABAmanda M. Bunting
Amanda M. Bunting
DJDon Des Jarlais
Don Des Jarlais

14 May 2024 in PLOS ONE
Verified
Journal Article
Open access
PDF file
MKMehrdad Khezri
Mehrdad Khezri
CMCourtney McKnight
Courtney McKnight
CWChenziheng Allen Weng
Chenziheng Allen Weng
SKSarah Kimball
Sarah Kimball
DJDon Des Jarlais
Don Des Jarlais
Background: Persons who inject drugs (PWID) may be unengaged with healthcare services and face an elevated risk of severe morbidity and mortality associated with COVID-19 due to chronic diseases and structural inequities. However, data on COVID-19 vaccine uptake, particularly booster vaccination, among PWID are limited. We examined COVID-19 vaccine uptake and factors associated with booster vaccination among PWID in New York City (NYC). Methods: We recruited PWID using respondent-driven sampling from October 2021 to November 2023 in a survey that included HIV and SARS-CoV-2 antibodies testing. The questionnaire included demographics, COVID-19 vaccination and attitudes, and drug use behaviors. Results: Of 436 PWID, 80% received at least one COVID-19 vaccine dose. Among individuals who received at least one COVID-19 vaccine dose, 95% were fully vaccinated. After excluding participants recruited before booster authorization for general adults started in NYC, and those who had never received an initial vaccination, 41% reported having received a COVID-19 booster vaccine dose. COVID-19 booster vaccination was significantly associated with having a high school diploma or GED (adjusted odds ratio (aOR) 1.93; 95% confidence interval (CI) 1.09, 3.48), ever received the hepatitis A/B vaccine (aOR 2.23; 95% CI 1.27, 3.96), main drug use other than heroin/speedball, fentanyl and stimulants (aOR 14.4; 95% CI 2.32, 280), number of non-fatal overdoses (aOR 0.35; 95% CI 0.16, 0.70), and mean vaccination attitude score (aOR 0.94; 95% CI 0.89, 0.98). Conclusions: We found a suboptimal level of COVID-19 booster vaccination among PWID, which was consistent with the rates observed in the general population in NYC and the U.S. Community-based interventions are needed to improve COVID-19 booster vaccination access and uptake among PWID. Attitudes towards vaccination were significant predictors of both primary and booster vaccination uptake. Outreach efforts focusing on improving attitudes towards vaccination and educational programs are essential for reducing hesitancy and increasing booster vaccination uptake among PWID.